BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 15, 2016
View Archived Issues
Cobitolimod approved as the international nonproprietary name for Kappaproct
Read More
Shanghai Haiyan Pharmaceutical and Yangtze River Pharmaceutical Group report EGFR inhibitors
Read More
Atlantic Healthcare initiates phase III trial of alicaforsen to treat IBD pouchitis
Read More
FDA grants Novartis' dabrafenib orphan drug designation for malignant glioma
Read More
Regeneron's evinacumab granted U.S. orphan status for homozygous familial hypercholesterolemia
Read More
siRNA ALN-GO1 given FDA orphan designation for treating primary hyperoxaluria type 1
Read More
Shire reports key developments of fourth quarter 2015
Read More
Unique mechanism uncovered for high-risk leukemia
Read More
Filaggrin inhibits formation of lipid antigens in human skin
Read More
PDS Biotechnology and NCI to codevelop novel cancer immunotherapies
Read More
FDA issues complete response letter for Remune BLA
Read More
Boehringer Ingelheim Pharma patents DPP-I inhibitors
Read More
Ferrer discloses antibacterial agents
Read More
Roche patent describes TaR-1 ligands
Read More
Merck & Co. reports development of CETP inhibitors
Read More
Zealand initiates phase II trial of ZP-1848 for short bowel syndrome
Read More
Janssen Pharmaceutica divulges mGlu2 receptor modulators
Read More
e-Therapeutics reports topline phase IIb results for ETS-6103 in major depressive disorder
Read More
JHL Biotech cleared to begin phase I study of rituximab biosimilar JHL-1101
Read More
Discovery of a novel RNA delivery system to treat B-cell malignancies
Read More
M3 Biotechnology completes series A financing, to move lead compound into clinic
Read More
Ennaid Therapeutics to develop therapy for Zika virus
Read More
XBiotech enters agreement regarding antibodies for cardiovascular diseases
Read More
Achillion Pharmaceuticals begins clinical study of complement factor D inhibitor
Read More
FDA awards orphan drug designation to NVX-508 for VOC and ACS in sickle cell disease
Read More
Regeneron Pharmaceuticals joins Human Vaccines Project
Read More
Incyte to discontinue solid tumor studies of ruxolitinib
Read More
